Accord Logo

Intended for UK patients and members of the public

Pentazocine Tablets

Active Ingredients

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Pentazocine Tablets BP 25mg

PL Number:
0142/0313
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Description of update:

    To update sections 4.2, 4.4, 4.7, 4.8, 5.1 and 5.3 of the SmPC in line with the reference product Pentazocine 25mg Tablets (PL: 11311/0529; MAH: Tillomed Laboratories Limited; Dated: 20/12/2022). Consequently, the PIL has been updated.

    Additionally, editorial updates have been made to section 4.8 of the SmPC and the PIL, and the headings in sections 1, 7 and 4.8 of the SmPC and the PIL have been updated in line with the QRD template.

    Furthermore, section 5.1 of the SmPC has been updated in line with the WHO ATC index and the PIL has been updated to align the excipient information for lactose with the latest EC Excipient guidelines.

    SmPC sections updated: 1, 4.2, 4.4, 4.7, 4.8, 5.1, 5.3, 7 and 10.

  • Description of update:

    To update sections 4.2, 4.4, 4.7, 4.8, 5.1 and 5.3 of the SmPC in line with the reference product Pentazocine 25mg Tablets (PL: 11311/0529; MAH: Tillomed Laboratories Limited; Dated: 20/12/2022). Consequently, the PIL has been updated.

    Additionally, editorial updates have been made to section 4.8 of the SmPC and the PIL, and the headings in sections 1, 7 and 4.8 of the SmPC and the PIL have been updated in line with the QRD template.

    Furthermore, section 5.1 of the SmPC has been updated in line with the WHO ATC index and the PIL has been updated to align the excipient information for lactose with the latest EC Excipient guidelines.

    PIL sections updated: Index, 2, 3, 4, 5 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: